- Home
- PHGE vs PETZ Comparison
PHGE vs PETZ Comparison
Compare PHGE & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- PETZ
- Stock Information
- Founded
- PHGE 2015
- PETZ 2002
- Country
- PHGE Israel
- PETZ China
- Employees
- PHGE N/A
- PETZ N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- PETZ Steel/Iron Ore
- Sector
- PHGE Health Care
- PETZ Industrials
- Exchange
- PHGE Nasdaq
- PETZ Nasdaq
- Market Cap
- PHGE 11.0M
- PETZ 9.3M
- IPO Year
- PHGE N/A
- PETZ 2017
- Fundamental
- Price
- PHGE $0.39
- PETZ $0.99
- Analyst Decision
- PHGE Strong Buy
- PETZ
- Analyst Count
- PHGE 1
- PETZ 0
- Target Price
- PHGE $15.00
- PETZ N/A
- AVG Volume (30 Days)
- PHGE 3.0M
- PETZ 5.9K
- Earning Date
- PHGE 08-13-2025
- PETZ 04-28-2025
- Dividend Yield
- PHGE N/A
- PETZ N/A
- EPS Growth
- PHGE N/A
- PETZ N/A
- EPS
- PHGE N/A
- PETZ 0.26
- Revenue
- PHGE N/A
- PETZ $563,726.00
- Revenue This Year
- PHGE N/A
- PETZ N/A
- Revenue Next Year
- PHGE N/A
- PETZ N/A
- P/E Ratio
- PHGE N/A
- PETZ $5.09
- Revenue Growth
- PHGE N/A
- PETZ 74664.72
- 52 Week Low
- PHGE $0.34
- PETZ $0.65
- 52 Week High
- PHGE $3.48
- PETZ $1.74
- Technical
- Relative Strength Index (RSI)
- PHGE 37.11
- PETZ 53.95
- Support Level
- PHGE $0.38
- PETZ $0.95
- Resistance Level
- PHGE $0.77
- PETZ $1.10
- Average True Range (ATR)
- PHGE 0.06
- PETZ 0.07
- MACD
- PHGE -0.00
- PETZ 0.01
- Stochastic Oscillator
- PHGE 6.52
- PETZ 68.91
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.